PROGENITY, INC. Business Finance Contracts & Agreements
71 Contracts & Agreements
- Credit Agreements (6 contracts)
- Exchange Agreements (3)
- Indenture Agreements (5)
- Investor Rights Agreements (7)
- Note Agreements (4)
- Purchase Agreements (7)
- Registration Rights Agreements (2)
- Security Agreements (1)
- Stock Agreements (11)
- Underwriting Agreements (3)
- Warrant Agreements (22)
- Form of Voting Agreement (attached as Exhibit D to the Form of Securities Purchase Agreement) (Filed With SEC on April 2, 2024)
- Form of March 2024 Private Placement Warrant (Filed With SEC on April 2, 2024)
- Second Supplemental Indenture, dated as of March 12, 2024, between Biora Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on April 1, 2024)
- First Supplemental Indenture, dated as of December 19, 2023, between Biora Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on April 1, 2024)
- Form of Registration Rights Agreement, to be dated as of the Closing Date, between the Company and the investor named therein (Filed With SEC on March 11, 2024)
- Form of Note Purchase Agreement, dated March 8, 2024, between the Company and the purchaser named therein (Filed With SEC on March 11, 2024)
- Form of Note Exchange Agreement, dated March 8, 2024, between the Company and the holder named therein (Filed With SEC on March 11, 2024)
- Form of March 2024 Warrant (Filed With SEC on March 11, 2024)
- Form of Supplemental Indenture, to be dated as of the Closing Date, between the Company, the guarantors party thereto and GLAS Trust Company LLC (Filed With SEC on March 11, 2024)
- Form of Registration Rights Agreement, to be dated as of the Closing Date, between the Company and the investors named therein (Filed With SEC on December 18, 2023)
- Form of Security Agreement, to be dated as of the Closing Date, between the Company, as issuer, subsidiaries of the Company, as guarantors, and GLAS Trust Company LLC, as... (Filed With SEC on December 18, 2023)
- Form of Note Purchase Agreement, dated December 18, 2023, between the Company and the purchasers named therein (Filed With SEC on December 18, 2023)
- Form of Note Exchange Agreement, dated December 18, 2023, between the Company and the holders named therein (Filed With SEC on December 18, 2023)
- Form of Additional Warrant (Filed With SEC on December 18, 2023)
- Form of Commitment Warrant (Filed With SEC on December 18, 2023)
- Form of Exchange Warrant (Filed With SEC on December 18, 2023)
- Indenture, to be dated as of the Closing Date, between the Company and GLAS Trust Company LLC (Filed With SEC on December 18, 2023)
- Purchase and Sale Agreement, dated October 6, 2023, by and among Biora Therapeutics, Inc. and Lynxdx, Inc (Filed With SEC on November 13, 2023)
- Form of October 2023 Private Placement Warrant (Filed With SEC on October 11, 2023)
- Convertible Notes Exchange Agreement for Common Stock and Warrants, dated September 18, 2023, by and among, the Company, Athyrium Opportunities III Acquisition LP and Athyrium... (Filed With SEC on September 19, 2023)
- Amendment No. 4 to Fourth Amended and Restated Investors Rights Agreement, dated as of September 18, 2023, by and among Biora Therapeutics, Inc., and certain of its stockholders (Filed With SEC on September 19, 2023)
- Form of September 2023 Warrant (Filed With SEC on September 19, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on September 19, 2023)
- Form of Warrant (Filed With SEC on June 14, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 14, 2023)
- Form of Amended Warrant ($2.84 warrants) (Filed With SEC on November 9, 2022)
- Form of Amended Warrant ($6.86 warrants) (Filed With SEC on November 9, 2022)
- Form of Warrant (Filed With SEC on November 9, 2022)
- Form of Securities Purchase Agreement, dated November 6, 2022, by and between the Company and the Purchasers signatory therein (Filed With SEC on November 9, 2022)
- Form of Inducement Plan Stock Option Award Agreement (Filed With SEC on March 28, 2022)
- Form of 2021 Inducement Plan Stock Option Grant Notice (Filed With SEC on March 28, 2022)
- 2020 Employee Stock Purchase Plan (Filed With SEC on March 28, 2022)
- Form of Securities Purchase Agreement, dated October 4, 2021, by and between the Company and the Purchasers signatory therein (Filed With SEC on October 6, 2021)
- Form of Warrant (Filed With SEC on August 23, 2021)
- Underwriting Agreement, dated as of August 19, 2021 (Filed With SEC on August 23, 2021)
- Amendment No. 3 to Fourth Amended and Restated Investors Rights Agreement, dated as of May 31, 2021, by and among Progenity, Inc., and certain of its stockholders (Filed With SEC on August 12, 2021)
- Amendment No. 3 to Fourth Amended and Restated Investors Rights Agreement, dated as of May 27, 2021, by and among Progenity, Inc. and certain of its stockholders (Filed With SEC on June 18, 2021)
- Securities Purchase Agreement, dated June 9, 2021, by and between the Company and the Purchasers signatory thereto (Filed With SEC on June 14, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on June 14, 2021)
- Form of Warrant (Filed With SEC on June 14, 2021)